Who founded BioNTech?

BioNTech was founded by Ozlem Tureci, Ugur Sahin.

Who are BioNTech's investors?

BioNTech's investors include Manta Ray Ventures, MIG Capital AG, Onsight Ventures, Pfizer Venture Investments, Salvia.

How much funding has BioNTech raised?

BioNTech has disclosed $400M raised across 2 of its 5 known rounds.

Where is BioNTech headquartered?

BioNTech is headquartered in Mainz.

BioNTech

Mainz · 5 known investors

Find your way into BioNTech

575 people in our graph share verified history with the BioNTech team — schools, employers, funds. One of them is your warm intro.

Nhi Lêunlockedknows Ryan Richardson · together at Bios Life (overlapped)

×4knows the team · via Instadeep

×5knows the team · via Eisenhower Fellowships

knows the team · via Universitätsspital Zürich

knows the team · via PRA Health Sciences

BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions. It operates globally in the pharmaceutical and biotech industry.

Biotech Healthtech

Founders & leadership

Ozlem TureciCo-founder

Ugur Sahin Co-founderFounder and CEO of BioNTech, Ugur Sahin is a medical doctor with a background in scientific research and a focus on translating research into therapeutic applications across oncology and infectious disease.

Sierk PoettingExecutive

Sean MarettExecutive

Ryan Richardson ExecutiveRyan Richardson has held senior healthcare leadership roles spanning more than two decades, including Chief Strategy Officer of BioNTech from 2018 to 2025, where he led corporate development through the company's Nasdaq IPO and financing rounds supporting its COVID-19 and oncology programs. He has advised multiple biotech companies, chaired Instadeep, and serves on the board of Autolus Therapeutics.

Board

Christoph Huber Board directorAdvisory Board at Onsight Ventures

Michael Motschmann Board directorManaging Partner at MIG Capital AG

Helmut JeggleBoard director

Ulrich WandschneiderBoard director

Investors · 5

Manta Ray Ventureslisted by Manta Ray VenturesLondon

How we know: Manta Ray Ventures's portfolio page · Not right? Tell us

MIG Capital AGlisted by MIG Capital AGMunich · $1.1M – $10.8M

How we know: MIG Capital AG's portfolio page · board seat on SEC Form D · Not right? Tell us

Onsight Ventureslisted by Onsight VenturesInnsbruck · $216K – $2.2M

How we know: Onsight Ventures's portfolio page · Not right? Tell us

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us

Salvialisted by SalviaHolzkirchen

How we know: Salvia's portfolio page · Not right? Tell us

Funding

SEC filings, press & company announcements

$400M disclosed across 2 of 5 rounds · 2019–2026

Undisclosed amountseedAug 2026
Source ↗

▶$150MraisedApr 2022 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Ryan RichardsonExecutive Officer
Ugur SahinExecutive Officer
Michael MotschmannDirector
Sierk PoettingExecutive Officer
Christoph HuberDirector
Jens HolsteinExecutive Officer
Ozlem TureciExecutive Officer
Ulrich WandschneiderDirector
Sean MarettExecutive Officer
Helmut JeggleDirector

Offering amount: $150M
Amount sold: $150M
First sale: Apr 2022
Incorporated: Corporation, Germany
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$250MraisedSep 2020 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sierk PoettingExecutive Officer
Sean MarettExecutive Officer
Ulrich WandschneiderDirector
Christoph HuberDirector
Ozlem TureciExecutive Officer
Michael MotschmannDirector
Ugur SahinExecutive Officer
Helmut JeggleDirector
Ryan RichardsonExecutive Officer

Offering amount: $250M
Amount sold: $250M
First sale: Sep 2020
Incorporated: Corporation, Germany
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does BioNTech do?: BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions. It operates globally in the pharmaceutical and biotech industry.
Who founded BioNTech?: BioNTech was founded by Ozlem Tureci, Ugur Sahin.
Who are BioNTech's investors?: BioNTech's investors include Manta Ray Ventures, MIG Capital AG, Onsight Ventures, Pfizer Venture Investments, Salvia.
How much funding has BioNTech raised?: BioNTech has disclosed $400M raised across 2 of its 5 known rounds.
Where is BioNTech headquartered?: BioNTech is headquartered in Mainz.